HGH Frag 2 mg
Educational recon guide for a 2 mg HGH Fragment 176-191 research vial and microgram daily unit mapping. Research use only.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
2 mg
Your BAC water
1 mL
Concentration
2.00 mg/mL
Per unit
~20.0 mcg
Frequency
Once or twice daily subcutaneous (often fasted morning ± pre-activity)
Route
Subcutaneous
Live reconstitution calculator
Defaults match this guide (2 mg + 1 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).
Quick select (mcg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
10 units
Volume
0.100 mL
Doses per vial
10
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 10 u
Fill one 30-unit U-100 syringe to about 10 units (0.100 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (1 mL BAC → 2.00 mg/mL · 20.0 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Research-community tables commonly cite ~200–500 mcg per day (sometimes split AM/PM) for multi-week courses. Related to AOD-9604 lipolytic fragment discussions.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Days 1–7 (intro) | 200 mcg0.2 mg | 10 u | 0.10 mL200 mcg daily |
| Days 8–28 (standard) | 350 mcg0.35 mg | 17.5 u | 0.17 mL350 mcg daily |
| Days 29–42 (optional) | 500 mcg0.5 mg | 25 u | 0.25 mL500 mcg daily |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Split total · 250 mcg per injection | 250 mcg0.25 mg | 12.5 u | 0.13 mLEach injection 250 mcg; count BID draws in supplies if twice daily |
Supplies planner
Using the guide’s phase ladder (200 mcg → 350 mcg → 500 mcg per injection (phase ladder)) over a 42-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
1 mL · 2.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
42-day course
HGH Frag 2 mg vials
8 vials
~15.75 mg mg total peptide over this 42-day course at 200 mcg → 350 mcg → 500 mcg per injection (phase ladder). Each vial holds 2 mg.
Bacteriostatic water
3 × 3 mL or 1 × 10 mL
1 mL BAC per vial × 8 vials = 8.0 mL total. Buy as 3× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
42+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~100 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 2 mg HGH Fragment 176-191 vial and bacteriostatic water to reach room temperature.
- Draw 1.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "2.0 mg/mL — 1 mL BAC").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·C-terminal hGH fragment marketed for fat-metabolism research — not full somatropin.
- ·Calculator: 0.2 mg = 200 mcg.
- ·Research use only.
Research context & considerations
Fragment 176-191 is associated with lipolytic research without the full anabolic GH cascade. Evidence quality is limited relative to modern metabolic drugs.
- ·Injection-site irritation.
- ·Not FDA-approved as a research-vial fat-loss drug.
- ·Pregnancy out of scope.
Catalog match
HGH Fragment 176-191 (FR2)
2mg x 10 vials · from $20